Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Does US cancer drug nod make Cipla attractive?
Mint Mumbai
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
Diese Geschichte stammt aus der April 18, 2025-Ausgabe von Mint Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Mumbai
Mint Mumbai
Anil Ambani moves SC over fraud tag
Industrialist Anil Ambani has moved the Supreme Court challenging an order of the Bombay High Court which upheld the State Bank of India’s (SBI) decision classifying his and Reliance Communications’ accounts as fraud.
1 min
December 02, 2025
Mint Mumbai
Mehli Mistry quits Ratan Tata’s Small Animal Hospital
Tata Trusts’ former trustee and late Ratan Tata’s close confidant, Mehli Mistry, has resigned from the board of his friend's cherished project, Small Animal Hospital Trust, which claims to have become India’s largest specialty hospital for pet animals.
1 mins
December 02, 2025
Mint Mumbai
KOCHI'S BOATS CHART A NATIONAL COURSE
India wants to modernize its ancient waterways for mass transit. Can it be a game changer?
8 mins
December 02, 2025
Mint Mumbai
Airbus flags new problem on some A320s
Airbus said on Monday it has discovered an industrial quality issue affecting metal panels of a “limited” number of A320family aircraft, confirming a Reuters report, the latest challenge for the planemaker after a weekend recall of its jets.
2 mins
December 02, 2025
Mint Mumbai
Ola woes grow, bets on battery
Ola Electric Mobility Ltd had its own set of problems, and the goods and servicestax (GST) rate cut from 28% to 18% on ICE two-wheelers has only made matters worse.
2 mins
December 02, 2025
Mint Mumbai
Equity market fails to hold gains
India’s equity benchmarks struggled to hold onto record highs on Monday as investors worried that outflows might persist amid uncertainty over a trade deal with the US.
1 min
December 02, 2025
Mint Mumbai
Why Aakash’s fundraise is now a proxy fight over Byju’s ownership
Beset Aakash Educational Services Ltd (AESL) thought a $250-crore rights issue would be its big reset after senior exits and a swing to losses in FY23.
3 mins
December 02, 2025
Mint Mumbai
Switzerland votes decisively against inheritance tax
THE YOUNG Socialists, the youth wing of Switzerland’s Social Democratic Party, do not have any MPs in parliament, but they know how to make a stir.
3 mins
December 02, 2025
Mint Mumbai
Delhi High Court asks govt, CCI to justify Apple penalty
HC seeks explanation on why penalties are based on global turnover instead of India revenue
3 mins
December 02, 2025
Mint Mumbai
IT’S A HOLD FOR NOW FOR THE MPC, TRACING TRADE TALKS FOR PATH AHEAD
Economists often defer to the quote by Keynes, ‘When my information changes, I alter my conclusions’, and Friday evening turned out to be one such case.
3 mins
December 02, 2025
Listen
Translate
Change font size